Important progress for Diamyd Medical during the third quarter

Diamyd Medical’s President and CEO comments in the company’s interim report today on several significant advances during the period, including the positive development of the company’s Phase III program.“I’m very pleased with how the operations has developed this quarter,” says Elisabeth Lindner, President and CEO of Diamyd Medical. “Patient recruitment for the European Phase III study is very successful. Now when we have also received approval to include children from age 10 in the US, we can further accelerate the recruitment," Lindner continues. Diamyd Medical announced during the third